These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
239 related items for PubMed ID: 16197472
1. High sensitivity of basophils predicts side-effects in venom immunotherapy. Kosnik M, Silar M, Bajrovic N, Music E, Korosec P. Allergy; 2005 Nov; 60(11):1401-6. PubMed ID: 16197472 [Abstract] [Full Text] [Related]
2. The basophil activation test in wasp venom allergy: sensitivity, specificity and monitoring specific immunotherapy. Erdmann SM, Sachs B, Kwiecien R, Moll-Slodowy S, Sauer I, Merk HF. Allergy; 2004 Oct; 59(10):1102-9. PubMed ID: 15355470 [Abstract] [Full Text] [Related]
3. Basophil sensitivity in patients not responding to venom immunotherapy. Peternelj A, Silar M, Erzen R, Kosnik M, Korosec P. Int Arch Allergy Immunol; 2008 Oct; 146(3):248-54. PubMed ID: 18270492 [Abstract] [Full Text] [Related]
4. Flow-assisted quantification of in vitro activated basophils in the diagnosis of wasp venom allergy and follow-up of wasp venom immunotherapy. Ebo DG, Hagendorens MM, Schuerwegh AJ, Beirens LM, Bridts CH, De Clerck LS, Stevens WJ. Cytometry B Clin Cytom; 2007 May; 72(3):196-203. PubMed ID: 17111386 [Abstract] [Full Text] [Related]
5. Predicting side-effects in venom immunotherapy by basophil activation? Eberlein-König B, Schmidt-Leidescher C, Behrendt H, Ring J. Allergy; 2006 Jul; 61(7):897. PubMed ID: 16792593 [No Abstract] [Full Text] [Related]
6. In vitro basophil activation using CD63 expression in patients with bee and wasp venom allergy. Eberlein-König B, Schmidt-Leidescher C, Rakoski J, Behrendt H, Ring J. J Investig Allergol Clin Immunol; 2006 Jul; 16(1):5-10. PubMed ID: 16599242 [Abstract] [Full Text] [Related]
7. Safety of specific immunotherapy using a four-hour ultra-rush induction scheme in bee and wasp allergy. Roll A, Hofbauer G, Ballmer-Weber BK, Schmid-Grendelmeier P. J Investig Allergol Clin Immunol; 2006 Jul; 16(2):79-85. PubMed ID: 16689180 [Abstract] [Full Text] [Related]
8. Basophil activation can predict clinical sensitivity in patients after venom immunotherapy. Kucera P, Cvackova M, Hulikova K, Juzova O, Pachl J. J Investig Allergol Clin Immunol; 2010 Jul; 20(2):110-6. PubMed ID: 20461965 [Abstract] [Full Text] [Related]
9. Surface membrane antigen alteration on blood basophils in patients with Hymenoptera venom allergy under immunotherapy. Siegmund R, Vogelsang H, Machnik A, Herrmann D. J Allergy Clin Immunol; 2000 Dec; 106(6):1190-5. PubMed ID: 11112905 [Abstract] [Full Text] [Related]
10. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses. Ruëff F, Wenderoth A, Przybilla B. J Allergy Clin Immunol; 2001 Dec; 108(6):1027-32. PubMed ID: 11742283 [Abstract] [Full Text] [Related]
14. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy. Pereira Santos MC, Pedro E, Spínola Santos A, Branco Ferreira M, Palma Carlos ML, Palma Carlos AG. Eur Ann Allergy Clin Immunol; 2005 Sep; 37(7):273-8. PubMed ID: 16285233 [Abstract] [Full Text] [Related]
16. The VISYT trial: Venom Immunotherapy Safety and Tolerability with purified vs nonpurified extracts. Bilò MB, Severino M, Cilia M, Pio A, Casino G, Ferrarini E, Campodonico P, Milani M. Ann Allergy Asthma Immunol; 2009 Jul; 103(1):57-61. PubMed ID: 19663128 [Abstract] [Full Text] [Related]
19. Monitoring honeybee venom immunotherapy in children with the basophil activation test. Žitnik SE, Vesel T, Avčin T, Šilar M, Košnik M, Korošec P. Pediatr Allergy Immunol; 2012 Mar; 23(2):166-72. PubMed ID: 22136583 [Abstract] [Full Text] [Related]